Umbilical cord blood is highly enriched with pluripotent stem cells which are considered lifesaving in later stages of life as they can treat a host of disorders. Cord blood stem cells are used to target blood disorders, immune deficiencies and rare metabolic disorders, including leukaemia, Krabbe disease, aplastic anaemia, non-Hodgkin’s lymphoma and Hodgkin’s lymphoma, sickle-cell anaemia and thalassemia, with least chances of rejection by the body. Cord blood preservation of new born babies, also termed as, stem cell banking, in public or family banks, is gaining a lot of awareness among people as it holds promise for future well-being.
• Global market of cord blood preservation
• Clinical aspects of stem cell banking